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We report on a nine years old girl born after 41 weeks of normal gestation with psychomotor retardation, speech
delay and minimal dysmorphic signs: antimongolic cut eyes, small mouth, short philtrum and hypertelorism.
The use of the high-resolution Affymetrix Human Mapping GeneChip 250 K NspI array allowed the characterization
of a de novo 1Mb deletion on the short arm (p22) of a chromosome 8. Molecular cytogenetic-FISH with BAC probes
(RP11) confirmed the deletion. The deleted region includes part of the sarcoglycan zeta (SGCZ) gene, involved in
the sarcoglycan complex formation, and the microRNA 383. The deletion described in our patient falls 319 Kb
upstream of the Tumor Suppressor Candidate 3 (TUSC3) gene. In this chromosomal region, a limited number of
cases of overlapping deletions, of variable extensions and characterized by heterogeneous clinical phenotype, have
been reported. The deleted region described in our patient is the smallest among those so far described in this region.
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Chromosomal aberrations are considered to be the most
frequent cause of unexplained developmental delay (DD),
intellectual disability (ID) and multiple congenital anomal-
ies (MCA). Emerging and increasing availability and sen-
sitivity of the technologies, new molecular cytogenetic,
array-based whole genome screening, showed that the
contribution of chromosomal aberrations in ID is not lim-
ited to the extent evidenced by karyotyping alone (6–10%)
but can be increased to as high as 20–30% using the men-
tioned methods [1]. Interstitial microdeletion and micro-
duplication syndromes account for 50–60% of the total
submicroscopic chromosomal abnormalities detected in
ID/MCA patients. In the course of a systematic screening
of patients with unexplained ID, by the use of the high-
resolution SNP-array, we have identified, in a 9 years-old
patient affected by mild ID, a de novo 1Mb interstitial
deletion in the 8p22.3 chromosomal region overlapping* Correspondence: piovani@med.unibs.it
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TUSC3 gene.
The discovery of new patients with microdeletions in
8p22 will lead to a better understanding of the roles that
the deleted genes play in the clinical outcome and will
facilitate both comprehensive medical care and accurate
recurrence risk assessment for the family.Case presentation
The proband is the second female child of non consan-
guineous Caucasian parents. Both her parents and her
sister are healthy and familiar history is negative for
malformation or developmental delay.
The patient was delivered uneventfully at 41 weeks of
gestation after a normal pregnancy without intrauterine
infection. No prenatal diagnosis was performed.
At birth, the weight was 3,470 g (50th centile) and length
was 50 cm (50th centile); in subsequent evaluations she
showed regular stature-weight growth and slight delay in
the acquisition of motor milestones. She demonstrated
episodes of bronchiolitis and ocular examinations revealed
congenital strabismus and hypotonia with minimal dys-
morphic signs. These were antimongolic cut eyes, smallLtd. This is an Open Access article distributed under the terms of the Creative
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and tapered fingers, feet with long toes, valgus knee
and only one groove of the right hand. At the age of six
years, when admitted to the school, she showed evident
psychomotor retardation and speech delay. Reduced
muscle tone was associated with distal ligamentous lax-
ity, and preserved diadococinesia, hindrance in distal
mobility as reported in coordination exercises and
fingers singolarization.
Brain MRI showed presence of moderate signal hyper-
intensity in the long TR sequences involving posterirly
the periventricular white matter of the radiated crowns
in a symmetrical way, being of uncertain significance.
There was a delay in language capacity primarily on
the expressive side. Simple orders understanding cap-
ability was preserved but difficulty in comprehension or-
ders has been recorded. Spontaneous words were poorly
understood, and moderate hindrance in the execution of
praxis bucco-lingual.
The general development quotient (Griffiths score)
was below the normal value, 64, with discordant trend;
decrease in hearing-language score, (53.8), and hand-eye
coordination, (59), was recorded. The global evaluation ofFigure 1 Visualisation of the 8p22 interstitial deletion. A Genotype an
GenotypeColour. The column corresponding to the genotype profile of the
the squares depends on the SNP genotype, whereas their height is propor
proband, a partial deletion of chromosome 8, characterized by the absence
indicated by the white arrow. B FISH analysis on metaphase spread derived
RP11-399 J23 (control probe) are in red and green, respectively. The chrom
RP11-399 J23 control probe. C UCSC Genome browser image of the 8p23.1
displayed together with those reported by [3-6]. The genes annotated in thcognitive performances revealed a low grade of mental
retardation requiring psycho-pedagogical help.
At the last examination at 8 years of age, the clinical
picture was unchanged.Results
Affymetrix mapping human 250 K NspI array and copy-number
analysis
The SNP-array analysis evidenced in our patient a de novo
interstitial deletion of 1Mb at 8p22. The proximal break-
point mapped between 14,089,730 bp (SNP_A-2290138 last
probe not deleted) and 14,105,921 bp (SNP_A-1992355 first
deleted probe); while the distal breakpoint was located be-
tween 15,078,161 bp (SNP_A-2133346) and 15,092,243 bp
(SNP_A-2103758) (last probe deleted and first not deleted,
respectively) (Figure 1A).Cytogenetic and FISH analysis
Chromosome preparations revealed a normal, (46,XX), fe-
male karyotype. The BAC clones, RP11-21H13 and RP11-
399 J23, used in FISH experiments, confirmed the deletion
(Figure 1B).d CN state visualisation of SNPs on short arm of chromosome 8 with
proband is made of many squares symbolizing SNPs; the colour of
tional to their CN states. See Barlati et al. [17] for references. In the
of heterozygous genotypes and squares of reduced height, is
from the proband. Signals derived from BAC clones RP11-21H13 and
osome 8 with the deletion displayed only the signal for the
-p21.3 region. The deletion described in our patient (red bar) is
is region are reported at the bottom of the figure.
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the same probes, showed absence of the deletion in the
parents.
The bioinformatic analysis of the sequences involved
in the chromosomal rearrangements was carried out
using the University of California Santa Cruz (UCSC)
Genome Browser [2] on the NCBI build GRCh37 of the
human genome.
Sequencing of the TUSC3 gene
The sequencing of the coding region of the TUSC3 gene
did not highlight the presence of deleterious functional
variants.
Discussion
We report a 1Mb interstitial deletion in the 8p22 locus
identified in a girl with psychomotor and speech delay.
Standard cytogenetic analysis resulted in a normal karyo-
type and only subsequent analysis by SNP array revealed a
deletion in the short arm of one chromosome 8.
In literature, deletions of this region are reported in a
small number of cases [3-6]. In the majority of cases,
the deletions spam from band p22 to the subtelomeric
region and include, therefore, a large part of the short
arm of chromosome 8. The carriers of these deletions
show heterogeneous clinical phenotypes ranging from
mental retardation with minimal dysmorphic signs [6]
to important mental retardation [3] and dysmorphic
signs like narrow cranium, high forehead, epicanthic
folds, flat nasal bridge, low-set but normal ears, retro-
gnathy, short neck and broad chest with wide-set nip-
ples [5]. In addition, in some patients, the deletion of
chromosome 8p has been found associated also with
congenital heart malformations [3,4]. Our patient, with
low mental retardation, presents neither congenital
heart malformations nor the major dysmorphic signs
described in other patients. The heterogeneity and the
dissimilarities of the observed clinical phenotypes are
mainly due to the differences in the size of the deletions
and in their different percentage of overlapping. In the
earliest reports, the extent of the aberrations was de-
tected only by standard cytogenetic analysis therefore a
molecular characterization of old cases would be desir-
able to perform better genotype to phenotype corre-
lations. To date our deletion highlighted with new
techniques is one of the smallest so far described in the
8p22 locus.
The observed de novo 8p22 deletion includes 3 out of
the 8 exons of the sarcoglycan zeta gene (SGCZ) and the
entire microRNA (miRNA) 383 (Figure 1C). The SGCZ
gene encodes for the ζ-sarcoglycan, one of the six proteins
(α, β, γ, δ, ε, ζ) constituting the sarcoglycan complex (SGC)
that provides a mechanosignaling connection from the
cytoskeleton to the extracellular matrix. Mutations in thesarcoglycan genes α-, β-, γ- and δ (in particular
deletions of exons), lead to a group of autosomal reces-
sive disorders defined limb girdle muscular dystrophies
(LGMD). Up to now, no neuromuscular disorders have
been correlated with mutations or partial deletions of
the ζ subunit gene. In our patient, no clinical sign over-
lapping those typical of the LGMDs was observed. This
suggests that if the SGCZ gene is involved in the LGMD
phenotype, as for the other sarcoglycan genes, two hits
are required for the onset of the disease. However, since
no neuromuscular disorders have been so far correlated
with the ζ subunit, we cannot exclude that CNVs in this
gene are neutral or responsible of a complete different
phenotype from that of dystrophies.
The DNA sequence inside intron 3 of SGCZ gene
encodes also for miR-383. miRNAs are short endogenous,
single-stranded RNAs that exert transcriptional and
post-transcriptional regulation of gene expression. Altered
miRNA expression levels have been found in the brains of
patients affected by ID, neurological and psychiatric dis-
eases, suggesting that their dysregulation may contribute
to these clinical phenotypes [7,8]. However in literature no
direct evidences are reported showing that deletions of
miR-383 impair neurodevelopment, but evidences of its
involvement in tumorigenesis are present. Actually, a re-
cent study demonstrated that miR-383 is an oncosuppres-
sor gene that directly targets Cyclin D1 and then inhibits
its downstream effectors. The authors also demonstrated
that a decreased expression of miR-383 can deregulate the
cyclin-dependent kinase 4 expression and promote DNA
damage and the onset of testicular embryonal carcinoma
[9]. Therefore we cannot exclude that the deletion de-
scribed in our patient might predispose to tumour devel-
opment, and a follow up of the patient in the future years
would be advisable.
The deletion described in our patient falls 319 Kb
upstream of the Tumor Suppressor Candidate 3 (TUSC3)
gene (Figure 1C) encoding a subunit of the ER-bound
oligosaccharyltransferase (OST) complex that catalyzes a
pivotal step in the protein N-glycosylation process [10].
Homozygous mutations and deletions inside this gene
have been described both in patients with nonsyndromic
autosomal recessive form of mental retardation (MIM
#611093) [10-14] and in a patient with few dysmorphic
features and a syndromic ID [15]. Heterozygous mutations
and deletions of TUSC3, instead, have been reported in
healthy subjects. The phenotype of our patient (moderate
mental retardation and only mild dysmorphic traits) is
compatible with that of impairment of TUSC3 gene; but
the sequencing of the coding region of the gene did not
highlight the presence of deleterious functional variants
that in combination with the deletion upstream of the
gene could point to the involvement of TUSC3 in the
pathological phenotype. We cannot exclude, however, the
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alter the transcription level of the gene.
Conclusions
In conclusion our patient with slight mental retardation
and speech delay carries a de novo 1Mb deletion never
observed before in healthy subjects that could be re-
sponsible of the clinical phenotype and that could also
represent a risk factor for cancer development in adult-
hood. Only the discovery of others patients with micro-
deletions overlapping to that described in our patient
will lead to a better understanding of the roles of the
deleted genes in the clinical outcome.
Materials and methods
Affymetrix mapping human 250 K NspI array and copy-
number analysis
The DNA of the proband was analysed with the Affymetrix
GeneChip Human Mapping 250 K NspI arrays and proc-
essed according to the instructions provided in the Affy-
metrix GeneChip Human Mapping 500 K Assay Manual.
Initial analysis and quality assessment of the array data
were performed using GTYPE 4.1. Copy number state de-
termination was performed with the Affymetrix CNAT4
software. The copy number state determination analysis
was performed by comparing our sample with a reference
set of 48 Hapmap samples available on the Affymetrix web
site [16]. The genotype and copy number state of the
patient genome were visualized with GenotypeColour
software [17].
Cytogenetic and FISH analysis
Chromosome preparations were obtained on cultured
pheripheral lymphocytes and performed according with
standard cytogenetic protocol using QFQ banding at 450
bands resolution. The BAC clones, used in FISH experi-
ments, were provided by CHORI [18]. Fluorescence in
situ hybridisation (FISH) was performed as described
previously [19].
Sequencing of the TUSC3 gene
The exons of the TUSC3 gene were sequenced on an ABI
PRISM 3100 sequencer (Applied Biosystems, Foster City,
CA) according to standard methods. Primers sequences
and sequence conditions are available upon request.
Consent
Written informed consent was obtained from the patient’s
parent for publication of this Case report and any accom-
panying images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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